Drug-Induced Liver Injury Due To Losartan

Drug-Induced Liver Injury Due To Losartan

Drug-induced liver injury (DILI) is a challenging diagnosis since a wide variety of medicines can cause adverse reactions. Losartan is an angiotensin II receptor antagonist (ARA-II) approved for the treatment of arterial hypertension. The most common adverse effects are fatigue, anaemia, weakness an...

Full description

Bibliographic Details
Main Authors:	Joana Diogo, Rita Monteiro, Carolina Coelho, Angela Ghiletchi, Rodrigo Leão, Conceição Loureiro
Format:	Article
Language:	English
Published:	SMC MEDIA SRL 2021-11-01
Series:	European Journal of Case Reports in Internal Medicine
Subjects:	losartan drug-induced liver injury
Online Access:	https://www.ejcrim.com/index.php/EJCRIM/article/view/2856

Similar Items

Losartan-induced ischemic hepatocellular hepatotoxicity: A case report and literature review
by: Moh′d Z Al-Halawani, et al.
Published: (2014-01-01)

Determination of Losartan and Losartan Carboxylic acid in Human Plasma by New HPLC Method with Fluorescence Detection for Pharmacokinetics Studies
by: Ahmed Abbas Hussein
Published: (2014-12-01)

Neuroprotective Effect of Losartan after Traumatic Brain Injury in Male Rats Based on Marmarou Model
by: Sh Shadi, et al.
Published: (2022-03-01)

Pleiotropic Effects of Losartan in Hypertensive Patients with Dyslipidemia
by: Sivakumar Sivasubramaniam, et al.
Published: (2017-09-01)

The Effectivity of Losartan Tablet for Decreasing Fibrotic Tissue Formation in Gastrocnemius Muscle Injury Grade I of Rabbits
by: Boby Harul Priono, et al.
Published: (2019-04-01)

Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats
by: H.A. Murad, et al.
Published: (2017-09-01)

Effects of losartan in patients with NAFLD: A meta-analysis of randomized controlled trial
by: Meng Chang, et al.
Published: (2023-03-01)

Losartan and QT Dispersion in Hypertensive Patients on Maintenance Hemodialysis
by: Alparslan Ersoy, et al.
Published: (2014-12-01)

Optimized and Validated RP-UPLC Method for the Determination of Losartan Potassium and Chlorthalidone in Pharmaceutical Formulations
by: Tadiboyina Sirisha, et al.
Published: (2015-03-01)

The role of angiotensin receptor antagonists in treatment of arterial hypertension: focus on losartan
by: Galina Anatol'evna Baryshnikova, et al.
Published: (2009-03-01)

Angiotensin receptor blockers in nephroprotection at patients with diabetes mellitus: focus on losartan
by: Ol'ga Konstantinovna Vikulova, et al.
Published: (2009-09-01)

Comparison of Anti Hypertensive Effect of Fixed Dose Enalapril and Losartan in Essential Hypertension
by: Khurram Mansoor
Published: (2009-06-01)

Losartan versus enalapril in dogs asymptomatic carriers of myxomatous degeneration of mitral valve
by: EDNA GOMEZ ORTIZ, et al.
Published: (2014-01-01)

Development and evaluation of sustained release losartan potassium matrix tablet using kollidon SR as release retardant
by: Shahid Sarwar, et al.
Published: (2012-12-01)

Effects of Captopril and Losartan on Cardiac Stereology in Rats with Renovascular Hypertension
by: Ali Akbar Nekooeian, et al.
Published: (2021-05-01)

Comparison of the GPVI inhibitors losartan and honokiol
by: Marie-Blanche Onselaer, et al.
Published: (2020-02-01)

Expert Approaches to the Assessment of Losartan Drugs Bioequivalence
by: D. P. Romodanovsky, et al.
Published: (2020-02-01)

Drug-induced Liver Injury Due to a Horse Chestnut Dietary Supplement
by: Diogo Costa Santos, et al.
Published: (2021-03-01)

Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
by: Goran Kekovic, et al.
Published: (2012-01-01)

Efficacy of fixed-dose amlodipine and losartan combination compared with amlodipine monotherapy in stage 2 hypertension: a randomized, double blind, multicenter study
by: Lee Hae-Young, et al.
Published: (2011-10-01)

Effects of the DASH diet and losartan on serum urate among adults with hypertension: Results of a randomized trial
by: Noelle Castilla‐Ojo, et al.
Published: (2023-10-01)

Drug-Induced Liver Injuries (Clinical Guidelines for Physicians)
by: Vladimir T. Ivashkin, et al.
Published: (2019-03-01)

The effect of angiotensin 1-7 and losartan on renal ischemic/reperfusion injury in male rats
by: Tahereh Safari, et al.
Published: (2019-01-01)

Drug-induced liver injury due to varenicline: a case report
by: Sprague David, et al.
Published: (2012-06-01)

Evaluation of Chronic Losartan Treatment Effect on Cardiac Chronotropic Dysfunction in Biliary Cirrhotic Rats
by: Farahnaz Jazaeri, et al.
Published: (2018-02-01)

ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE
by: R. M. Linchak, et al.
Published: (2016-01-01)

Evaluation of drug-induced liver injury as etiology for acute liver failure in Brazil
by: Genario Santos, et al.
Published: (2021-07-01)

Losartan Reduces Remodeling and Apoptosis in an Adriamycin-Induced Cardiomyopathy Rat Model
by: Hyeon A Kim, et al.
Published: (2023-09-01)

Investigations on Synperiplanar and Antiperiplanar Isomers of Losartan: Theoretical and Experimental NMR Studies
by: Jacek Kujawski, et al.
Published: (2015-06-01)

Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats
by: Gabriel Mulinari-Santos, et al.

Synergistic effects of sitagliptin and losartan against fipronil-induced hepatotoxicity in rats
by: Sara T. Elazab, et al.
Published: (2021-07-01)

COMPARTMENTAL MODELING APPROACH OF LOSARTAN TRANSDERMAL TRANSPORT IN VITRO
by: Akhmad Kharis Nugroho, et al.
Published: (2014-01-01)

Determining the Effects of Morphine, Heroin, and Losartan and the Interaction of each on Losartan in Water Homeostasis Mechanisms by the Kidney in Adult Male Rabbits
by: F Foroohi, et al.
Published: (2015-04-01)

Losartan potassium dissolution test for drug release evaluation in pharmaceutical capsules using HPLC and UV spectrophotometry
by: Rudy Bonfilio, et al.
Published: (2010-01-01)

Urinary Metabolomic Profiling in Streptozotocin-Induced Diabetic Mice after Treatment with Losartan
by: Jin Seong Hyeon, et al.
Published: (2020-11-01)

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2008-10-01)

Changes of and genes in the left ventricle of spontaneously hypertensive rat after losartan treatment
by: Hyeryon Lee, et al.
Published: (2019-03-01)

Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis
by: Qing Li, et al.
Published: (2022-11-01)

Skin fibroblasts of patients with geleophysic dysplasia due to FBN1 mutations have lysosomal inclusions and losartan improves their microfibril deposition defect
by: Pasquale Piccolo, et al.
Published: (2019-09-01)

The abilities of losartan in angioprotection in hypertensive patients with hyperuricemia
by: S V Nedogoda, et al.
Published: (2012-12-01)